Contraceptive steroid concentrations in women with early active schistosomiasis: lack of effect of antischistosomal drugs.
Plasma concentrations of the oral contraceptive steroids (OCS) ethinyloestradiol (EE2) and levonorgestrel (LNG) have been determined in women with early active schistosomiasis and compared to those obtained in healthy volunteers. Steroid concentrations following a single dose of Ovral (500 micrograms LNG, 50 micrograms EE2) or during a multiple dose regimen were unaffected by the disease. There was no significant effect of the antischistosomal drugs praziquantel (40 mg X kg-1) or metrifonate (10 mg X kg-1 X 3 at 2-week intervals) on plasma steroid concentrations. In regular users of OCS, significantly higher concentrations of LNG were observed than in women who received only a single dose. We conclude that there is no pharmacokinetic reason for withholding OCS from patients with early active schistosomiasis who are also receiving either praziquantel or metrifonate.
D000293:Adolescent; D000328:Adult; D004347:Drug Interactions; D004997:Ethinyl Estradiol / Q000097:blood*; D005260:Female; D006801:Humans; D016912:Levonorgestrel; D009644:Norgestrel / Q000097:blood*; D011223:Praziquantel / Q000494:pharmacology; D012552:Schistosomiasis / Q000097:blood* / Q000188:drug therapy; D012556:Schistosomicides / Q000494:pharmacology*; D014236:Trichlorfon / Q000494:pharmacology
D012556:Schistosomicides; D009644:Norgestrel; D004997:Ethinyl Estradiol; D016912:Levonorgestrel; D011223:Praziquantel; D014236:Trichlorfon